Managed virological reaction after treatment with daclatasvir/pegylated interferon and ribavirin as a component of a clinical trial in a cirrhotic human immunodeficiency infection . AJAHR [Internet]. 2015 Apr. 19 [cited 2026 Oct. 28];3(1):23-5. Available from: https://kevinpage.org/index.php/AJAHR/article/view/700